Painting a new picture of personalised medicine for diabetes (Q38402805)

http://europepmc.org/abstract/PMC/6518376

30 June 2019

2 references

14 November 2020

4 February 2021

Painting a new picture of personalised medicine for diabetes (English)

1 reference

http://europepmc.org/abstract/PMC/6518376

30 June 2019

1 reference

14 November 2020

2 references

14 November 2020

4 February 2021

corrigendum / erratum

Erratum to: Painting a new picture of personalised medicine for diabetes.

0 references

Mark I McCarthy

1

0 references

publication date

7 February 2017

1 reference

http://europepmc.org/abstract/PMC/6518376

30 June 2019

1 May 2017

2 references

14 November 2020

4 February 2021

3 references

http://europepmc.org/abstract/PMC/6518376

30 June 2019

14 November 2020

4 February 2021

60

1 reference

http://europepmc.org/abstract/PMC/6518376

30 June 2019

issue

5

1 reference

http://europepmc.org/abstract/PMC/6518376

30 June 2019

page(s)

793-799

1 reference

http://europepmc.org/abstract/PMC/6518376

30 June 2019

copyright license

Creative Commons Attribution 4.0 International

2 references

14 November 2020

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.

4 February 2021

0 references

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Personalized Nutrition by Prediction of Glycemic Responses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Declassifying diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Towards precision medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Predictive, preventive, personalized and participatory medicine: back to the future

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Identification of type 2 diabetes subgroups through topological analysis of patient similarity

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Treating young adults with type 2 diabetes or monogenic diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

The genetic architecture of type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Exposing the exposures responsible for type 2 diabetes and obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Diabetes mellitus in the texts of old Hindu medicine (Charaka, Susruta, Vagbhata).

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28175964

12 December 2020

10.1007/S00125-017-4210-X

Identifiers

DOI

1 reference

http://europepmc.org/abstract/PMC/6518376

30 June 2019

Dimensions Publication ID

0 references

1 reference

http://europepmc.org/abstract/PMC/6518376

30 June 2019

PubMed publication ID

28175964

1 reference